Kantar Health in the News

Filter by

Therapeutic Area / Research

Year Starting

Year Ending

Search News:
Showing 1 to 10 of 549

Drugmakers set their sights on the next potential blockbuster disease: NASH

MM&M, Sep 29, 2016

With at least 20 global Phase-II clinical trials, blockbuster sales estimates, and millions of prospective patients, the market for NASH, or non-alcoholic steatohepatitis, is viewed in many ways as one of the largest potential categories for new drugs in recent years.

Read more | Share

Hypertension most common risk factor for Chinese heart disease patients

Kantar China Insights, Sep 29, 2016

Chinese patients are not paying enough attention to control heart disease.

Read more | Share

World Heart Day: fighting against high cholesterol

Kantar Spain Insights, Sep 29, 2016

46% of Spaniards have high cholesterol and 35% have hypertension.

Read more | Share

Pfizer Launches Global Innovation Challenge to Enrich the Lives of Patients Living with Metastatic Breast Cancer (mBC)

Pfizer Press Release, Sep 27, 2016

Metastatic breast cancer is the most advanced type of breast cancer in which the tumor cells spread beyond the breast to other parts of the body, potentially affecting the bones, liver, lungs or brain. While progress in patient care has been made in the past decade, there is still a need for improvements in care and support among patients living with this disease.

Read more | Share

The Next Wave of Immunotherapies: Costimulators

Oncology Business Review, Sep 19, 2016

Immunotherapies have been in the cancer landscape now for more than 15 years and have made a large impact in the clinic. With over 3,400 cancer therapies in development, immunotherapies have risen to the top of the crowded field.

Read more | Share

With small RetroSense deal, Allergan hoping for big win

MedCity News, Sep 12, 2016

Allergan’s recent deal for gene therapy company RetroSense Therapeutics, based in Ann Arbor, Michigan, could be a nice win for the big biotech.

Read more | Share

Sport and technology are allies in overcoming limits

MediAvataar, Sep 11, 2016

Competitions help stimulate the creation of better facilities for those who deal with disabilities.

Read more | Share

Paralympics: Sport and technology are allies in overcoming limits

Kantar Brazil Insights, Sep 6, 2016

Competitions help stimulate the creation of better facilities for those who deal with disabilities.

Read more | Share

Germany Puts Focus on Pharma Innovation

PharmaVOICE, Sep 1, 2016

The fourth largest economy in the world and the largest in Europe, Germany remains one of the world’s economic powerhouses.

Read more | Share

The rise of people-watching research carried out by brands

Raconteur, Sep 1, 2016

People-watching can get you into trouble, but not if it’s an ethnographic study with volunteers surrendering to researchers who are trying to understand lifestyles from a business perspective.

Read more | Share
Page  < 12345678910 >